Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
Apollo Therapeutics, a collaboration between three drug firms and tech transfer offices at three UK universities, has licensed its first product—a gene therapy developed at University College London—to the health-care investment firm Deerfield Management. Deerfield will further the research at its new laboratory in New York City. Apollo was formed in 2016 to translate academic research into medicines. Apollo CEO Richard Butt says he expects further licensing progress this year.
This article has been sent to the following recipient: